Genetic factors for individual administration of immunosuppressants in organ transplantation

来源 :国际肝胆胰疾病杂志:英文版 | 被引量 : 0次 | 上传用户:yzahnig621
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
【正】BACKGROUND: The immunosuppressive drugs used worldwide have a narrow therapeutic index, which results in a need to individualize the dose regimen for different recipients. The oxidative enzymes cytochrome P450 (CYP)3A and the drug efflux pump P-glycopr
其他文献
BACKGROUND:Bangladesh is situated in the intermediate prevalence region of hepatitis B virus (HBV).The lifetime risk of acquiring HBV infection in Bangladesh is
BACKGROUND: When liver or kidney transplant can respectively cure end-stage liver or kidney disease, neither hepatic graft nor renal transplant alone can be use
BACKGROUND:A suitable perfusate is very important in reducing various problems in liver preservation,prolonging the time of organ preservation and enhancing the
【正】BACKGROUND: The prognosis of decompensated cirrhosis resulting from chronic hepatitis B is poor, and the benefits of treatment with interferon are ourweig
【正】BACKGROUND: It is reported that Shenfu injection (an injection prepared from traditional Chinese medicines red ginseng and aconite root) can decrease the
BACKGROUND: Brain-dead donors are the main sources for organ transplantation, but many studies show that brain-death affects the organ’s function after transpl